Pfizer Inc. (NYSE: PFE) last traded at $28.07, up 1.01% on the session. The quote above updates while this page is open; the figures below are drawn from Pfizer Inc.’s own filings and are restated only when a new one is published.
Pfizer Inc. trades on NYSE under the ticker PFE. It is classified in the Healthcare sector, Pharmaceuticals industry. Its market capitalisation is $159.99 billion.
Healthcare sectorPharmaceuticalsListed on NYSE
Valuation measures for Pfizer Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $159.99B |
|---|---|
| Enterprise value | $274.65B |
| P/E ratio | 36.93 |
| Price / sales | 2.51 |
| Price / book | 1.88 |
| Beta | 0.32 |
Trailing-twelve-month figures tagged in Pfizer Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $63.70B |
|---|---|
| Net income (TTM) | $4.33B |
| EPS (TTM) | $0.760 |
| Return on equity | 5.09% |
| Cash | $976.00M |
Range and volume for PFE over the past 52 weeks.
| 52-week high | $28.75 |
|---|---|
| 52-week low | $23.58 |
| Volume | 37.07M |
| Average volume | 42.29M |
| Previous close | $27.79 |
Dividend history for Pfizer Inc. over the trailing twelve months.
| Dividend yield | 6.13% |
|---|---|
| Dividend per share (TTM) | $1.72 |
| Payout ratio | 226.32% |
Other Healthcare companies tracked on FurlPay Markets.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.